MX2015006454A - Composiciones fibrinoliticas que comprendes bromelaina y nattoquinasa para la prevencion y tratamiento de estados flebotromoticos. - Google Patents

Composiciones fibrinoliticas que comprendes bromelaina y nattoquinasa para la prevencion y tratamiento de estados flebotromoticos.

Info

Publication number
MX2015006454A
MX2015006454A MX2015006454A MX2015006454A MX2015006454A MX 2015006454 A MX2015006454 A MX 2015006454A MX 2015006454 A MX2015006454 A MX 2015006454A MX 2015006454 A MX2015006454 A MX 2015006454A MX 2015006454 A MX2015006454 A MX 2015006454A
Authority
MX
Mexico
Prior art keywords
nattokinase
bromelain
phlebothrombotic
prevention
states
Prior art date
Application number
MX2015006454A
Other languages
English (en)
Inventor
Pierro Francesco Di
Original Assignee
Velleja Res S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Velleja Res S R L filed Critical Velleja Res S R L
Publication of MX2015006454A publication Critical patent/MX2015006454A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21062—Subtilisin (3.4.21.62)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22032—Stem bromelain (3.4.22.32)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicinal Preparation (AREA)
  • External Artificial Organs (AREA)
  • Materials For Medical Uses (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Se divulgan composiciones que comprenden bromelaína y nattoquinasa como sus únicos ingredientes activos.
MX2015006454A 2012-11-23 2013-11-06 Composiciones fibrinoliticas que comprendes bromelaina y nattoquinasa para la prevencion y tratamiento de estados flebotromoticos. MX2015006454A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001997A ITMI20121997A1 (it) 2012-11-23 2012-11-23 Composizioni fibrinolitiche per la prevenzione e il trattamento degli stati flebotrombotici
PCT/EP2013/073160 WO2014079689A1 (en) 2012-11-23 2013-11-06 Fibrinolytic compositions comprising bromelain and nattokinase for the prevention and treatment of phlebothrombotic states

Publications (1)

Publication Number Publication Date
MX2015006454A true MX2015006454A (es) 2015-12-03

Family

ID=47633139

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015006454A MX2015006454A (es) 2012-11-23 2013-11-06 Composiciones fibrinoliticas que comprendes bromelaina y nattoquinasa para la prevencion y tratamiento de estados flebotromoticos.

Country Status (25)

Country Link
US (1) US20150297685A1 (es)
EP (1) EP2922567B1 (es)
JP (1) JP6319592B2 (es)
KR (1) KR20150100641A (es)
CN (1) CN104955474B (es)
AU (1) AU2013349898B2 (es)
BR (1) BR112015011693A2 (es)
CA (1) CA2892426A1 (es)
CY (1) CY1119064T1 (es)
DK (1) DK2922567T3 (es)
EA (1) EA027753B1 (es)
ES (1) ES2637847T3 (es)
GE (1) GEP201706717B (es)
HR (1) HRP20170987T1 (es)
HU (1) HUE034096T2 (es)
IL (1) IL238937A0 (es)
IT (1) ITMI20121997A1 (es)
LT (1) LT2922567T (es)
MX (1) MX2015006454A (es)
PH (1) PH12015501131B1 (es)
PL (1) PL2922567T3 (es)
PT (1) PT2922567T (es)
SI (1) SI2922567T1 (es)
WO (1) WO2014079689A1 (es)
ZA (1) ZA201503604B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11065310B2 (en) 2016-05-27 2021-07-20 Nattocat, LLC Compositions and methods for thromboembolism dissolution
CN105944091A (zh) * 2016-06-24 2016-09-21 方捷 抗血栓的纳豆激酶组合物及其制备方法
IT201600109433A1 (it) * 2016-10-28 2018-04-28 Difass Int S R L Composizioni gastroresistenti comprendenti bromelina associata a un estratto secco di ananas comosus (l.)
WO2020214033A1 (en) * 2019-04-17 2020-10-22 Erasmus University Medical Center Rotterdam Papain-like cysteine peptidase medicaments and uses thereof
JP2021017423A (ja) 2019-07-23 2021-02-15 株式会社Ｓｃｒｅｅｎホールディングス 灌流液および灌流方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003068202A1 (en) * 2002-02-15 2003-08-21 Dsm Ip Assets B.V. Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
JP2005220025A (ja) * 2004-02-03 2005-08-18 Kenko Tsusho Kk 経口摂取組成物
RU2318466C1 (ru) 2006-06-23 2008-03-10 Давид Георгиевич Кочиев Лазерная установка для абляции тканей и литотрипсии
US8287858B2 (en) * 2006-08-10 2012-10-16 Jon Barron Proteolytic enzyme formulations
AT504159A1 (de) * 2006-08-16 2008-03-15 Marlyn Nutraceuticals Inc Verwendung von proteasen
EP2167048B1 (en) * 2007-05-30 2016-10-26 Wockhardt Limited A novel tablet dosage form
AT506095A1 (de) * 2007-12-03 2009-06-15 Volopharm Gmbh Verwendung von proteasen
EP2504025A4 (en) * 2009-11-23 2013-05-01 Stephen F Olmstead COMPOSITIONS AND METHODS USING SERRATIA PEPTIDASE FOR INHIBITING AND TREATING BIOFILMS ASSOCIATED WITH PARTICULAR SUFFERING

Also Published As

Publication number Publication date
EP2922567A1 (en) 2015-09-30
IL238937A0 (en) 2015-07-30
EP2922567B1 (en) 2017-05-24
HRP20170987T1 (hr) 2017-09-22
PT2922567T (pt) 2017-08-28
BR112015011693A2 (pt) 2017-07-11
PH12015501131A1 (en) 2015-08-03
SI2922567T1 (sl) 2017-07-31
EA027753B1 (ru) 2017-08-31
LT2922567T (lt) 2017-07-25
JP6319592B2 (ja) 2018-05-09
AU2013349898A1 (en) 2015-06-11
DK2922567T3 (en) 2017-07-24
CA2892426A1 (en) 2014-05-30
EA201590796A1 (ru) 2015-09-30
PL2922567T3 (pl) 2017-10-31
KR20150100641A (ko) 2015-09-02
PH12015501131B1 (en) 2015-08-03
CN104955474B (zh) 2017-09-19
CN104955474A (zh) 2015-09-30
GEP201706717B (en) 2017-08-10
ES2637847T3 (es) 2017-10-17
WO2014079689A1 (en) 2014-05-30
HUE034096T2 (en) 2018-01-29
CY1119064T1 (el) 2018-01-10
US20150297685A1 (en) 2015-10-22
ITMI20121997A1 (it) 2014-05-24
ZA201503604B (en) 2016-08-31
JP2016504287A (ja) 2016-02-12
AU2013349898B2 (en) 2018-05-10

Similar Documents

Publication Publication Date Title
PH12019502809A1 (en) Substituted tricyclic compounds as fgfr inhibitors
MX337248B (es) Variantes de plasminogeno y plasmina.
MX2014001707A (es) Variantes de plasminogeno y plasmina.
NZ630805A (en) Pharmaceutical combinations comprising a thionucleotide analog
MY192088A (en) Combinantion therapy including an mdm2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers
MX2012000475A (es) Variantes de plasminogeno y plasmina.
SG10201903119QA (en) Polypeptide vaccine
IN2014MN02437A (es)
MX2013004061A (es) Analogos de ciclosporina.
HRP20170987T1 (hr) Fibrinolitički pripravci koji sadrže bromelain i natokinazu za sprječavanje i liječenje flebotrombotičkih stanja
MX349948B (es) Proteínas inmunógenas y composiciones para el tratamiento y prevención de streptococcus agalactiae.
MX2013004062A (es) Analogos de ciclosporina.
PH12015501302A1 (en) Compositions comprising vortioxetine and donepezil
MX2023003000A (es) Formulaciones de liberacion modificada de viloxacina.
MX2014011218A (es) Uso de agentes tensoactivos anfotericos para la prevencion y tratamiento de biopeliculas vaginales patogenas en infecciones vaginales.
WO2014031982A3 (en) Methods and compositions for treating pain
IN2014MN02257A (es)
MX2013005699A (es) Composiciones de interferon-beta estables conservadas.
GB201114923D0 (en) Immunogenic proteins and compositions
GB2519004A (en) Quinone compounds and their uses for the treatment of cancer
MY171941A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
HH Correction or change in general